Jan 7 (Reuters) - Eli Lilly (LLY.N), opens new tab will buy autoimmune drug developer Ventyx Biosciences (VTYX.O), opens new tab for $1.2 billion in cash, the companies said on Wednesday, marking the ...

Jan 6 (Reuters) - Eli Lilly (LLY.N), opens new tab is in advanced talks to buy Ventyx Biosciences (VTYX.O), opens new tab for more than $1 billion, the Wall Street Journal reported on Tuesday, citing ...

Boston biotech Nimbus Therapeutics is teaming up with Eli Lilly & Co. to develop a new oral obesity treatment in a deal worth up to $1.3 billion, the company announced Tuesday. It’s the latest move in ...

In the sunny landscapes of Southern California, where the flowers bloom and the sun shines bright, there is a buzzing hero known as Eli the Bee Guy. When it comes to beehive removal near me, Eli has ...

The Washington Nationals shocked everyone when they picked Eli Willits No. 1 in the 2025 draft. Long connected to Ethan Holliday and then later breakout collegiate pitcher Kade Anderson, the fact they ...

Eli Lilly LLY-0.58%decrease; red down pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...

Eli Lilly has surpassed analysts’ highest hopes for the efficacy of retatrutide, linking the triple agonist to 28.7% weight loss and a 75.8% reduction in pain scores in patients with obesity and knee ...

A key catalyst may be right around the corner. Though Lilly stock has climbed more than 100% over the past three years, I think it still has room to run in both the short term and the long term. Let's ...